Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Acadia Pharmaceuticals Inc ACAD Feb 23, 2018 31.52 +4.23   
 Acasti Pharma Inc ACST Feb 23, 2018 0.97 0.00   
 Accelerate Diagnostics Inc AXDX Feb 23, 2018 25.75 -0.77   
 Acceleron Pharma Inc XLRN Feb 23, 2018 42.91 +2.17   
 Access National Corp ANCX Feb 23, 2018 28.67 +0.56   
 Accuray Incorporated ARAY Feb 23, 2018 5.22 +3.47   
 Acelrx Pharmaceuticals ACRX Feb 23, 2018 1.80 -2.70   
 Aceto Corp ACET Feb 23, 2018 7.54 +4.58   
 Achaogen, Inc. AKAO Feb 23, 2018 10.99 +1.57   
 Achillion Pharmaceuticals ACHN Feb 23, 2018 2.96 +0.17   
 Aci Worldwide ACIW Feb 23, 2018 24.91 +5.19   
 Aclaris Therapeutics, Inc. ACRS Feb 23, 2018 20.19 +0.90   
 Acnb Corp ACNB Feb 23, 2018 28.25 +1.99   
 Acorda Therapeutics ACOR Feb 23, 2018 26.05 -1.33   
 Acorn Energy ACFN Feb 23, 2018 0.21 0.00   
 Active Alts Contrarian ETF SQZZ Feb 23, 2018 25.74 0.00   
 Activision Blizzard Inc ATVI Feb 23, 2018 72.07 +3.71   
 Actua Corporation ACTA Feb 23, 2018 0.71 0.00   
 Acura Pharmaceuticals ACUR Feb 23, 2018 0.35 0.00   
 ACWI Ex-US Index MSCI Ishares ACWX Feb 23, 2018 51.06 +1.09   
 ACWI Index MSCI Ishares ACWI Feb 23, 2018 73.99 +1.25   
 Acxiom Corp ACXM Feb 23, 2018 28.57 +2.15   
 Adamas Pharmaceuticals, Inc. ADMS Feb 23, 2018 26.02 -5.07   
 Adamis Pharmaceuticl ADMP Feb 23, 2018 3.35 +31.37   
 Adaptimmune Therapeutics plc ADAP Feb 23, 2018 7.88 +3.01   
 Addus Homecare Corp ADUS Feb 23, 2018 36.00 +0.28   
 Addvantage Technologies Group AEY Feb 23, 2018 1.34 +0.75   
 Adesto Technologies Corporation IOTS Feb 23, 2018 6.50 +0.78   
 ADMA Biologics Inc ADMA Feb 23, 2018 3.78 +0.27   
 Adobe Systems Incorporated ADBE Feb 23, 2018 209.74 +3.52   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now